IsoPlexis Granted U.S. Patent Titled ‘METHODS OF USING NUCLEOTIDE ANALOGUES’

Telsey Advisory Group analyst Dana Telsey reiterated a Market Perform rating on the shares of Kohl’s Corporation (NYSE: KSS) with a price target of $24.